Whereas subcutaneous alemtuzumab has already been used in hematological diseases, up to now, there is no evidence of its use in MS. Perumal et al. report two cases of aggressive MS who ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback